Farther Finance Advisors’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-20
Closed -$65 4357
2024
Q4
$65 Hold
20
﹤0.01% 3847
2024
Q3
$66 Sell
20
-2
-9% -$8 ﹤0.01% 3840
2024
Q2
$95 Sell
22
-25
-53% -$243 ﹤0.01% 3608
2024
Q1
$659 Hold
47
﹤0.01% 2931
2023
Q4
$452 Buy
+47
New +$325 ﹤0.01% 3003

Other funds holding MGNX

Farther Finance Advisors's MGNX Position: Q1 2025 in Review

Farther Finance Advisors sold out of MacroGenics (MGNX) in Q1 2025, closing a stake of 20 shares — an estimated $65 sold.

Farther Finance Advisors first reported a position in MGNX in Q4 2023 and held it in 5 quarters. The position peaked at $659 in Q1 2024. 128 funds tracked by Wall St. Rank hold MGNX as of Q1 2025.

  • Farther Finance Advisors reported no remaining MacroGenics position as of Q1 2025 after selling out during the quarter.
  • Farther Finance Advisors sold 20 MacroGenics shares in Q1 2025, an estimated $65.
  • Farther Finance Advisors first reported a position in MacroGenics in Q4 2023 and held it in 5 quarters.
  • Farther Finance Advisors's MacroGenics position peaked at $659 in Q1 2024.
  • 128 funds tracked by Wall St. Rank held MacroGenics as of Q1 2025.

Based on Farther Finance Advisors's 13F filing for Q1 2025, filed 14 Apr 2025.